Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 32,511

Document Document Title
WO/2016/161279A1
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, suc...  
WO/2016/158788A1
The present invention relates to: a fused heterocyclic compound that has enteropeptidase inhibitory activity; and use of the compound as a pharmaceutical product for treatment or prophylaxis of obesity, diabetes and the like. Specificall...  
WO/2016/159021A1
[Problem] To provide a novel compound. [Solution] A compound represented by formula (I) or formula (II), a salt thereof, or a solvate thereof. R1 represents a hydrogen atom or a halogen atom; each of R2-R4 represents a hydrogen atom, a h...  
WO/2016/158706A1
The purpose of the present invention is to provide an industrially advantageous method for producing a furan compound, by which a furan compound is able to be efficiently obtained from a furfural compound with high selectivity. The prese...  
WO/2016/157052A1
The present invention provides compounds represented by formula (1A), or pharmaceutically acceptable salts. Compounds represented by formula (1A), or pharmaceutically acceptable salts thereof, wherein A1 and A2 are identical or different...  
WO/2016/153937A1
A method for synthesizing furan-2, 5-dicarboxylate (FDCA2-) is provided. Furan-2-carboxylic acid is provided. A CO3 2- salt is provided to form a mixture, which converts the furan-2-carboxylic acid to furan-2-carboxylate. CO2 gas is prov...  
WO/2016/151989A1
The present invention can provide novel C-glycoside derivatives which are biologically important under high stereoselective, mild, atom economical condition.  
WO/2016/154599A1
Catalysts useful for the selective hydrogenation of carbonyl groups, including for the reduction of aldehydes to alcohols, are described. The catalysts incorporate palladium and rhenium on an alumina support. Methods of making the cataly...  
WO/2016/153432A1
The present invention relates to substituted phenyl cinnamyl ketones of Formula (I) for use in therapy: wherein R1 to R11 are defined as described in the specification, or a pharmaceutically acceptable salt, tautomer(s), solvate or polym...  
WO/2016/154241A1
The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses he...  
WO/2016/146769A1
A method of selective conversion of Abienol, represented by formula 1, to Sclareodial, represented by formula 2 by ozonolysis and subsequent reduction. The ozonolysis is carried out at temperatures above -60 °C, preferably in nonhalogen...  
WO/2016/148425A2
The present invention provides a compound represented by Chemical Formula 1. In addition, the present invention provides an organic electric device including a first electrode, a second electrode, and an organic layer between the first e...  
WO/2016/146752A1
The present invention pertains to a method for manufacturing furan-2, 5-dicarboxylic acid (FDCA) by converting a furan-2,5- dicarboxylate salt (MFDC) into furan-2, 5-dicarboxylic acid (FDCA), comprising the steps of - combining solid MFD...  
WO/2016/145478A1
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.  
WO/2016/148425A3
The present invention provides a compound represented by Chemical Formula 1. In addition, the present invention provides an organic electric device including a first electrode, a second electrode, and an organic layer between the first e...  
WO/2016/146689A1
Provided is an organozinc composition comprising (a) an organozinc complex carrying an allylic ligand, (b) a magnesium component and (c) a lithium component. The organozinc composition is useful as a synthetic intermediate with excellent...  
WO/2016/149461A1
The present disclosure provides methods to produce 5-(halomethyl)furfural, including 5- (chloromethyl)furfural, by acid-catalyzed conversion of C6 saccharides, including isomers thereof, polymers thereof, and certain derivatives thereof.  
WO/2016/145532A1
Described are methods and uses for treating or preventing fatty liver disease. Also provided are methods and uses for the treatment or prevention of insulin resistance. Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) is shown to p...  
WO/2016/146753A1
The invention pertains to a method for manufacturing furan-2,5-dicarboxylic acid (FDCA) by converting a furan-2,5-dicarboxylate salt (MFDC) into furan-2,5-dicarboxylic acid (FDCA), comprising the steps of combining an aqueous solution of...  
WO/2016/141148A1
The present invention provides a method of preparing a furan derivative comprising the steps of (a) converting a monosaccharide to provide a keto-intermediate product; and (b) dehydrating the keto-intermediate product to provide a furan ...  
WO/2016/137832A1
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected w...  
WO/2016/135268A1
The invention relates to a method for preparing a chemical compound from a starting compound in a contaminant containing feedstock, wherein the feedstock comprises a contaminant, wherein the contaminant is selected from the group consist...  
WO/2016/135009A1
The invention relates to process for the preparation of gamma valerolactone (GVL) from levulinic acid (LA), said process comprising a) subjecting LA to a hydrogenation reaction comprising hydrogen and a solid catalyst system comprising a...  
WO/2016/135542A1
A process for the production of dipentyl ether from levulinic acid resulting from biomass including at least one polysaccharide comprising the following steps: (a) reacting said levulinic acid in the presence of hydrogen and at least one...  
WO/2016/137068A1
The present specification provides a hetero ring compound and an organic luminescent element comprising same.  
WO/2016/135070A1
The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2016/133972A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV:  
WO/2016/131098A1
ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in ...  
WO/2016/133970A1
Compounds of Formula (I), including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.  
WO/2016/133963A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and areuseful in treating those infected with HCV.  
WO/2016/133160A1
The purpose of the present invention is to provide a novel low molecular weight compound that exhibits orexin receptor agonist activity and is expected to be useful as an excellent preventative or therapeutic agent for narcolepsy or the ...  
WO/2016/131098A8
The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treat...  
WO/2016/134013A1
A diesel fuel and additive mixture is useful for reducing particulate matter emissions while improving or at least not aggravating oxidative stability during combustion. The additive includes at least one compound having a general formul...  
WO/2016/131821A1
The invention relates to a continuous or repetitive batch process for the hydrogenation of levulinic acid (LA) or esters thereof to at least gamma valerolactone (GVL) in a reactor comprising a feed stream and an outlet stream, in the pre...  
WO/2016/131521A1
The present invention relates to spirobifluorene derivatives of formula (I), the use thereof in electronic devices, and methods for producing said derivatives.  
WO/2016/133948A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:  
WO/2016/131004A1
The integrated processes herein provide improved carbon efficiency for processes based on coal or biomass gasification or steam methane reforming. Provided are also ethylene oxide carbonylation products such as beta-propiolactone and suc...  
WO/2016/129819A1
The present invention relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent compound according to the present invention can be comprised in a light-...  
WO/2016/129607A1
 An objective of the present invention is to provide a method for manufacturing a fluorine-containing cyclo olefin compound in which a compound having a fluorine atom bonded directly to each carbon forming a carbon-carbon double bond t...  
WO/2016/128044A1
A method for the reduction organic molecules comprising a Ruthenium-Triphosphine complex with aromatic ligands at the phosphors which are ortho or meta substituted.  
WO/2016/127874A1
Disclosed are a method for preparing an anticoagulant, and an intermediate and a preparation method therefor. Provided is a method for preparing an intermediate IV of vorapaxar sulfate, which comprises the following steps: in an organic ...  
WO/2016/126973A1
Disclosed herein are processes for forming 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate:Formula (I)..  
WO/2016/125182A1
The present invention relates to compound of Formula (I) containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N -oxide, S-oxide, o...  
WO/2016/126975A1
Disclosed herein are processes for forming 2-furoic acid derivatives represented by Formula (I):.  
WO/2016/125782A1
As a chemically amplified resist, the present invention provides a resist and compound having a good balance by which line edge roughness (LER) is improved without impairing basic physical properties inherent in a resist, such as base ad...  
WO/2016/125871A1
Provided are a liquid crystal orientation agent enabling a liquid crystal display element having high response speed and excellent AC-derived afterimage characteristics, and a liquid crystal display element. The liquid crystal display el...  
WO/2016/124127A1
A photosensitive resin composition, containing ultraviolet photosensitive prepolymer resin, an active diluting monomer, an oxime ester photoinitiator represented by formula (I), and a colorant. The composition has good exposure sensibili...  
WO/2016/123361A1
An alternative approach to formation of a C-C bond at a meta-position of an aromatic compound is disclosed that employs an ethylenically unsaturated bicyclic compound as a transient mediator to achieve meta-selective C-H activation with ...  
WO/2016/119052A8
Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of usi...  
WO/2016/119052A1
Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of usi...  

Matches 701 - 750 out of 32,511